ArticleDrug delivery and translational research2026
PMVE/MA-based microneedle patches for rapid transdermal delivery of vitamin B12: fabrication and evaluation.
Article in Drug delivery and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin B12 (cyanocobalamin) deficiency is a prevalent global health issue which has been historically treated with oral supplements or intramuscular injections. In case of pernicious anemia, there is poor absorption of Vitamin B12 in the intestine, so injection is a typical treatment option. However, injections are painful and require a trained medical professional, which can often lead to the patient visiting clinics, thereby leading to patient non-compliance. In order to overcome these disadvantages, this research investigates an alternative, minimally invasive, and patient-friendly self-administration option, transdermal delivery via dissolvable microneedle (MN) patch. We fabricate a poly (methyl vinyl ether/maleic acid) (PMVE/MA) based MN patch, a biocompatible material, for the rapid delivery of cyanocobalamin. An in-house developed polydimethylsiloxane (PDMS) mold was used to prepare the MN patch. The MN patches were characterized by optical microscopy and scanning electron microscopy (SEM) to determine MN dimensions and morphology. Mechanical strength and skin penetration ability of the MNs were assessed through a universal testing machine (UTM) and a parafilm layer model. The findings suggest that 20% PMVE/MA formulation offered sufficient mechanical strength for skin penetration and more than 90% insertion efficiency which is total number of holes created by all the MNs. Dissolution of the needles was achieved within 45 s in agarose phantom and within 120 s in porcine skin. In vitro Franz diffusion experiments revealed continuous release, achieving a cumulative release mass of ~ 229 µg of vitamin B12 within 210 min. UV-Vis and FTIR analysis confirmed excellent B12 stability in the MN patch up to 60 days. The reported observations emphasize the advantages and the translational potential of PMVE/MA-based dissolvable MN patch as a safe, effective, and user-friendly system for the transdermal delivery of vitamin B12.
Indexed as
Identifiers
41708905What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.